EUVIMEDEUVIMED entdecken
Korrektur

Corrigendum to “Epcoritamab Monotherapy as Outpatient Treatment for Patients With Relapsed/Refractory Diffuse Large B-Cell Lymphoma: Interim Results From EPCORE NHL-6”[Clinical Lymphoma Myeloma and Leukemia 26 (2026) 317–327]

David Andorsky, Adelba Torres Lopez, Rakhee Vaidya, Fernando Vargas Madueno, Sami Ibrahimi, Seema Naik, Mitul Gandhi, Julie Erika Haydu, Bradley Lash, Mark Fesler, John Hrom, Eric H Lee und 11 weitere

Clinical Lymphoma Myeloma and Leukemia · 2026-11 · 26 (11) · e1275-e1277

DOI: 10.1016/j.clml.2026.08.006 ↗

Kurz gefasst

Korrektur in der Zeitschrift Clinical Lymphoma Myeloma and Leukemia, 2026-11. Verfasst von David Andorsky und 22 weiteren Autor:innen. Beteiligte Einrichtung: Sarah Cannon Research Institute at Rocky Mountain Cancer Centers, Boulder, CO. Electronic address: David.Andorsky@usoncology.com.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Autor:innen und Institutionen

  • Sarah Cannon Research Institute at Rocky Mountain Cancer Centers, Boulder, CO. Electronic address: David.Andorsky@usoncology.com.
  • Hospital Auxilio Mutuo, San Juan, PR.
  • Department of Hematology and Oncology, Atrium Wake Forest Baptist Health, Winston-Salem, NC.
  • Department of Hematology and Oncology, Moffitt Cancer Center at Memorial Healthcare System, Pembroke Pines, FL.
  • Department of Medicine, Section of Hematology and Medical Oncology, OU Health Stephenson Cancer Center, Oklahoma City, OK.
  • Department of Medicine, Division of Hematology and Oncology, Penn State Cancer Institute, Hershey, PA.

Zitieren

APA

Andorsky, D., Lopez, A. T., Vaidya, R., Madueno, F. V., Ibrahimi, S., Naik, S., Gandhi, M., Haydu, J. E., Lash, B., Fesler, M., Hrom, J., Lee, E. H., Sundaram, S., Conte, K., Osei-Bonsu, K., Doerr, T., Bai, Y., Dixit, N., Eskelund, C. W., …, & Sharman, J. P. (2026). Corrigendum to “Epcoritamab Monotherapy as Outpatient Treatment for Patients With Relapsed/Refractory Diffuse Large B-Cell Lymphoma: Interim Results From EPCORE NHL-6”[Clinical Lymphoma Myeloma and Leukemia 26 (2026) 317–327]. Clinical Lymphoma Myeloma and Leukemia, 26(11), e1275-e1277. https://doi.org/10.1016/j.clml.2026.08.006

Vancouver

Andorsky D, Lopez AT, Vaidya R, Madueno FV, Ibrahimi S, Naik S, et al. Corrigendum to “Epcoritamab Monotherapy as Outpatient Treatment for Patients With Relapsed/Refractory Diffuse Large B-Cell Lymphoma: Interim Results From EPCORE NHL-6”[Clinical Lymphoma Myeloma and Leukemia 26 (2026) 317–327]. Clinical Lymphoma Myeloma and Leukemia. 2026;26(11):e1275-e1277. doi:10.1016/j.clml.2026.08.006

BibTeX
@article{Andorsky2026,
  author = {Andorsky, David and Lopez, Adelba Torres and Vaidya, Rakhee and Madueno, Fernando Vargas and Ibrahimi, Sami and Naik, Seema and Gandhi, Mitul and Haydu, Julie Erika and Lash, Bradley and Fesler, Mark and Hrom, John and Lee, Eric H and Sundaram, Suchitra and Conte, Kristin and Osei-Bonsu, Kojo and Doerr, Thomas and Bai, Yang and Dixit, Neha and Eskelund, Christian W and Boardman, Alexander P and Boccia, Ralph and Lee, Christina Y and Sharman, Jeff P},
  title = {Corrigendum to “Epcoritamab Monotherapy as Outpatient Treatment for Patients With Relapsed/Refractory Diffuse Large B-Cell Lymphoma: Interim Results From EPCORE NHL-6”[Clinical Lymphoma Myeloma and Leukemia 26 (2026) 317–327]},
  journal = {Clinical Lymphoma Myeloma and Leukemia},
  year = {2026},
  volume = {26},
  number = {11},
  pages = {e1275--e1277},
  doi = {10.1016/j.clml.2026.08.006}
}
Kostenlos starten →